Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
PUT
Teradata
TDC
$2.47B
| $598K | ﹤0.01% |
19,300
+18,600
| +2,657% | +$628K |
|
4027
CALL
iShares Russell 2000 Value ETF
IWN
$14.6B
| $597K | ﹤0.01% |
5,000
-300
| -6% | -$35.4K |
|
4028
Fossil Group
FOSL
$349M
| $596K | ﹤0.01% |
47,601
-28,943
| -38% | -$328K |
|
4029
Helios Technologies
HLIO
$2.72B
| $596K | ﹤0.01% |
14,688
-4,202
| -22% | -$183K |
|
|
MNK
4030
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $596K | ﹤0.01% |
246,948
-14,039
| -5% | -$71.7K |
|
|
SLCA
4031
PUT
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $595K | ﹤0.01% |
62,200
+34,700
| +126% | +$400K |
|
|
ACHN
4032
DELISTED
Achillion Pharmaceuticals
ACHN
| $593K | ﹤0.01% |
164,707
-172
| -0.1% | -$663 |
|
4033
CALL
Cintas
CTAS
$80.6B
| $590K | ﹤0.01% |
+8,800
| New | +$563K |
|
4034
Coca-Cola Femsa
KOF
$22.7B
| $590K | ﹤0.01% |
9,730
+2,924
| +43% | +$177K |
|
4035
CALL
United Therapeutics
UTHR
$22B
| $590K | ﹤0.01% |
7,400
+2,900
| +64% | +$234K |
|
4036
Adtran
ADTN
$645M
| $589K | ﹤0.01% |
51,821
-40,145
| -44% | -$477K |
|
4037
American Vanguard Corp
AVD
$73.2M
| $589K | ﹤0.01% |
37,524
-5,706
| -13% | -$83.8K |
|
4038
DXP Enterprises
DXPE
$2.61B
| $588K | ﹤0.01% |
16,990
-2,527
| -13% | -$84.9K |
|
4039
Silicon Motion
SIMO
$8.36B
| $588K | ﹤0.01% |
16,621
-10,210
| -38% | -$370K |
|
|
PDLI
4040
DELISTED
PDL BioPharma, Inc.
PDLI
| $588K | ﹤0.01% |
272,399
+82,305
| +43% | +$220K |
|
4041
PUT
iShares MSCI Australia ETF
EWA
$1.44B
| $587K | ﹤0.01% |
26,400
+22,500
| +577% | +$497K |
|
4042
BGC Group
BGC
$5.18B
| $586K | ﹤0.01% |
106,526
-75,250
| -41% | -$403K |
|
4043
CALL
Copart
CPRT
$26.8B
| $586K | ﹤0.01% |
29,200
+4,400
| +18% | +$85.4K |
|
4044
St. Joe Company
JOE
$3.7B
| $586K | ﹤0.01% |
34,224
+7,953
| +30% | +$141K |
|
4045
PUT
Quanta Services
PWR
$103B
| $586K | ﹤0.01% |
15,500
-4,800
| -24% | -$173K |
|
4046
Tredegar Corp
TG
$271M
| $586K | ﹤0.01% |
29,978
-1,641
| -5% | -$28.8K |
|
|
AERI
4047
DELISTED
Aerie Pharmaceuticals
AERI
| $584K | ﹤0.01% |
30,350
-13,569
| -31% | -$311K |
|
4048
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.81B
| $583K | ﹤0.01% |
17,657
-35,943
| -67% | -$1.22M |
|
|
SHLX
4049
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $583K | ﹤0.01% |
28,547
-25,994
| -48% | -$536K |
|
4050
Charles River Laboratories
CRL
$12.6B
| $582K | ﹤0.01% |
4,393
-2,958
| -40% | -$397K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.